文献速递肿瘤 PET/CT核素与放射性配体治疗

术前⁶⁸Ga-FAPI-04 PET/CT肝纤维化定量可独立预测肝切除术后肝衰竭

Preoperative ⁶⁸Ga-FAPI-04 PET/CT-derived liver fibrosis quantification independently predicts post-hepatectomy liver failure: a histologically validated study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-05-27

该回顾性研究纳入107例肝癌患者,术前行⁶⁸Ga-FAPI-04 PET/CT定量肝纤维化并与病理分期相关。30例(28.0%)发生肝切除术后肝衰竭(PHLF),TBRmax、凝血酶原时间和大范围肝切除为独立预测因素,联合模型AUC为0.780。

要点

  • ⁶⁸Ga-FAPI-04 PET/CT定量参数随肝纤维化分期加重而显著升高。
  • TBRmax、凝血酶原时间和大范围肝切除为PHLF独立预测因素。
  • 联合三变量的列线图预测PHLF的AUC为0.780,校准良好。

核心结论

  • 术前⁶⁸Ga-FAPI-04 PET/CT可无创定量肝纤维化并经组织病理学验证,其衍生模型有助于PHLF术前风险分层。

研究设计与样本

  • 回顾性研究,纳入107例接受术前⁶⁸Ga-FAPI-04 PET/CT的肝癌患者,分析影像定量参数与病理纤维化分期及PHLF的关系。

主要发现

  • 30例(28.0%)患者发生PHLF。
  • 所有PET参数随纤维化分期进展显著升高(均P < 0.05)。
  • 多变量logistic回归显示TBRmax(OR = 4.590,95% CI 1.439至14.637,P = 0.010)、凝血酶原时间(OR = 1.566,95% CI 1.009至2.428,P = 0.045)和大范围肝切除(OR = 2.857,95% CI 1.065至7.665,P = 0.037)为PHLF独立预测因素。
  • 联合上述三变量的列线图AUC为0.780,校准满意,决策曲线分析显示净获益阳性。

临床怎么用

  • 对于常规临床标准评估可安全切除的患者,术前⁶⁸Ga-FAPI-04 PET/CT的TBRmax可辅助识别PHLF高风险者。
  • 结合TBRmax、凝血酶原时间和大范围肝切除的列线图可用于术前风险分层。

局限性

  • 本研究为回顾性、单中心设计,样本量有限,结论属假设生成性,需在独立队列中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Accurate preoperative risk stratification for post-hepatectomy liver failure (PHLF) is crucial. This study aimed to investigate whether, in patients deemed eligible for safe resection by conventional clinical criteria, ⁶⁸Ga-FAPI-04 PET/CT-based quantitative assessment of liver fibrosis could serve as a non-invasive predictor for PHLF. METHODS: In this retrospective study, 107 patients with liver cancer underwent preoperative ⁶⁸Ga-FAPI-04 PET/CT. Quantitative parameters, including liver SUVmax, SUVmean, SUVpeak, and liver-to-aorta SUV ratios (TBRs), were measured. These imaging metrics were correlated with histopathological fibrosis stage (S0-S4) and analyzed alongside clinical and surgical variables to identify independent predictors of PHLF. RESULTS: PHLF occurred in 30 (28.0%) patients. All PET parameters significantly increased with advancing fibrosis stage (all P < 0.05). Multivariable logistic regression identified TBRmax (odds ratio [OR] = 4.590, 95% CI 1.439 to 14.637, P = 0.010), prothrombin time (OR = 1.566, 95% CI 1.009 to 2.428, P = 0.045), and major hepatectomy (OR = 2.857, 95% CI 1.065 to 7.665, P = 0.037) as independent predictors of PHLF. A nomogram incorporating these three variables demonstrated good predictive performance, with an area under the curve of 0.780, satisfactory calibration, and positive net benefit on decision curve analysis. CONCLUSION: Preoperative ⁶⁸Ga-FAPI-04 PET/CT offers a histologically confirmed, non-invasive method to quantify liver fibrosis. This hypothesis-generating model offers a promising approach for preoperative risk stratification, warranting further validation in independent cohorts.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chen Q, Wang Y, Ou L, et al. Preoperative ⁶⁸Ga-FAPI-04 PET/CT-derived liver fibrosis quantification independently predicts post-hepatectomy liver failure: a histologically validated study. Eur J Nucl Med Mol Imaging. 2026. PMID: 42201381. doi:10.1007/s00259-026-07946-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。